scholarly journals Dopamine Inhibits Reproduction in Female Zebrafish (Danio rerio) via Three Pituitary D2 Receptor Subtypes

Endocrinology ◽  
2013 ◽  
Vol 154 (2) ◽  
pp. 807-818 ◽  
Author(s):  
Romain Fontaine ◽  
Pierre Affaticati ◽  
Kei Yamamoto ◽  
Cécile Jolly ◽  
Charlotte Bureau ◽  
...  

In many teleosts, the stimulatory control of gonadotrope axis by GnRH is opposed by an inhibitory control by dopamine (DA). The functional importance of this inhibitory pathway differs widely from one teleostean species to another. The zebrafish (Danio rerio) is a teleost fish that has become increasingly popular as an experimental vertebrate model. However, the role of DA in the neuroendocrine control of its reproduction has never been studied. Here the authors evaluated in sexually regressed female zebrafish the effects of in vivo treatments with a DA D2 receptor (D2-R) antagonist domperidone, or a GnRH agonist, alone and in combination, on the pituitary level of FSHβ and LHβ transcripts, the gonadosomatic index, and the ovarian histology. Only the double treatment with GnRH agonist and domperidone could induce an increase in the expression of LHβ, in the gonadosomatic index, and a stimulation of ovarian vitellogenesis, indicating that removal of dopaminergic inhibition is required for the stimulatory action of GnRH and reactivation of ovarian function to occur. Using double immunofluorescent staining on pituitary, the authors showed in this species the innervation of LH cells by tyrosine-hydroxylase immunoreactive fibers. Finally, using in situ hybridization and immunofluorescence, the authors showed that the three subtypes of zebrafish DA D2-R (D2a, D2b, and D2c) were expressed in LH-producing cells, suggesting that they all may be involved in mediating this inhibition. These results show for the first time that, in zebrafish, DA has a direct and potent inhibitory action capable of opposing the stimulatory effect of GnRH in the neuroendocrine control of reproduction.

2010 ◽  
Vol 22 (6) ◽  
pp. 1015 ◽  
Author(s):  
Erin L. Forbes ◽  
Craig D. Preston ◽  
P. Mark Lokman

Few studies have demonstrated plasticity of egg size within the confines of an egg size–number trade-off in response to trophic conditions in fishes. Moreover, the physiological mechanisms that govern this plasticity are not known. Growth differentiation factor 9 (Gdf9) and bone morphogenetic factor 15 (Bmp15) are oocyte-specific factors implicated in follicular growth and ovulation in mammals. In order to investigate whether expression levels of these genes were correlated with ration-dependent changes in fecundity in fish, zebrafish (Danio rerio) were subjected to four different feeding regimens. Counts of spawned eggs or vitellogenic follicles were used to estimate fecundity, whereas quantitative polymerase chain reaction analyses were performed to determine Gdf9 and Bmp15 mRNA levels in response to changes in ration size. Both relative fecundity and gonadosomatic index increased significantly with increased ration size, whereas egg size and hatching rate decreased significantly. No significant differences in Gdf9 or Bmp15 transcript abundance were evident between feeding regimens, suggesting that these growth factors do not govern fecundity in fish. However, favourable trophic conditions markedly affected follicle or egg size and number, with important implications for downstream egg quality and survival.


2020 ◽  
Vol 145 ◽  
pp. 176-180
Author(s):  
Andrzej Jurczak ◽  
Tomasz Janowski ◽  
Sławomir Zdunczyk ◽  
Klaus Failing ◽  
Gerhard Schuler ◽  
...  

2020 ◽  
Vol 513 ◽  
pp. 110858
Author(s):  
Yanlong Song ◽  
Ji Chen ◽  
Binbin Tao ◽  
Daji Luo ◽  
Zuoyan Zhu ◽  
...  
Keyword(s):  

Aquaculture ◽  
2008 ◽  
Vol 277 (3-4) ◽  
pp. 275-281 ◽  
Author(s):  
Annette Jaya-Ram ◽  
Meng-Kiat Kuah ◽  
Phaik-Siew Lim ◽  
Sagiv Kolkovski ◽  
Alexander Chong Shu-Chien

2002 ◽  
Vol 203 (2) ◽  
pp. 240-241 ◽  
Author(s):  
Martha Delaney ◽  
Christopher Follet ◽  
Nick Ryan ◽  
Nick Hanney ◽  
Jenny Lusk-Yablick ◽  
...  

Author(s):  
GB Young ◽  
B Mulroy ◽  
R Rafiq

Background: D2 receptor antagonists have been a mainstay in treating schizophrenia. Dopamine agonists used in the treatment of Parkinsonism can aggravate psychosis. Dopaminergic drugs with emphasis on other receptor subtypes with less D2 activation could reduce Parkinsonism in schizophrenic patients without seriously aggravating Parkinsonism. Rotigitine acts primarily on D3 receptors, while activity on other dopamine receptors is 8-20 times less. We report the successful treatment of a schizophenic patient with rotigitine and contend that its effectiveness relates to rotigitine’s receptor profile. Methods: Single case study with follow-up. Results: A 67 year old woman with longstanding schizophrenia developed severe, progressive Parkinsonian features over 2 years despite stable antipsychotic therapy. More than one tablet of levodopa-carbidopa 100/25 precipitated psychosis. Risperidone was changed to cloazapine without benefit in Parkinsonism. The rotigitine patch was introduced and increased to 8 mg/24 hours without aggravating her mental status and produced considerable improvement in Parkinsonian features. Conclusions: Rotigitine is worth exploring as a treatment for severe Parkinsonism in patients with schizophrenia.


Sign in / Sign up

Export Citation Format

Share Document